You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CISPLATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cisplatin, and what generic alternatives are available?

Cisplatin is a drug marketed by Accord Hlthcare, Bedford, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hq Spclt Pharma, Mylan Labs Ltd, Pharmachemie Bv, and Teva Pharms Usa. and is included in nine NDAs.

The generic ingredient in CISPLATIN is cisplatin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cisplatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cisplatin

A generic version of CISPLATIN was approved as cisplatin by PHARMACHEMIE BV on May 16th, 2000.

  Try a Trial

Summary for CISPLATIN
Drug patent expirations by year for CISPLATIN
Drug Prices for CISPLATIN

See drug prices for CISPLATIN

Recent Clinical Trials for CISPLATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dipenkumar ModiPhase 2
GenmabPhase 2
Guangxi Medical UniversityPhase 1/Phase 2

See all CISPLATIN clinical trials

Pharmacology for CISPLATIN
Medical Subject Heading (MeSH) Categories for CISPLATIN

US Patents and Regulatory Information for CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISPLATIN cisplatin INJECTABLE;INJECTION 206774-001 Aug 18, 2015 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 AP RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa CISPLATIN cisplatin INJECTABLE;INJECTION 074735-001 Jul 16, 1999 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 ⤷  Try a Trial ⤷  Try a Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 ⤷  Try a Trial ⤷  Try a Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CISPLATIN

See the table below for patents covering CISPLATIN around the world.

Country Patent Number Title Estimated Expiration
Italy 1116893 COMPOSIZIONE FARMACEUTICA ATTA A CONTRASTARE LA CRESCITA DI CELLULE TUMORALI ⤷  Try a Trial
Hungary 177557 PROCESS FOR PREPARING STABLE AEQUOUS STERILE SOLUTION OF CYS-PLATINIC/II/-DIAMINE-DICHLORIDE ⤷  Try a Trial
Ireland 790194 ⤷  Try a Trial
Finland 790404 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.